• Value Research Rating market-capitalisation-info
    UnratedSee Why?
  • Market Capitalisation market-capitalisation-info ₹32,824 Cr
  • Price to Earnings Ratio price-to-earning 42.49
  • 12 Month Earnings monthly-earning ₹772 Cr

Gland Pharma Ltd. Share Price

₹1,990.60

As on 19-Jul-2024 IST

up-down-arrow-19.15-0.95%

  • Prev Close info

    2,009.75

  • Day's Openinfo

    1,996.00

  • Today's Highinfo

    2,008.75

  • Today's Lowinfo

    1,963.35

  • Today's Volumeinfo

    1,15,987

  • 52 Week rangeinfo

    ₹1,158.00 - 2,194.00

Please wait...

Stock Range

Today’s Range
Low 1,963.35 High: 2,008.75
52 Week Range
Low 1,158.00 High: 2,194.00
Liquidity
Low High

Gland Pharma Ltd. Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Gland Pharma
3.43 8.21 12.82 71.43 -20.47 -- --
BSE Healthcare
20.94 2.76 10.36 44.85 13.20 24.02 12.42
BSE Mid Cap
25.57 0.01 15.19 57.22 25.99 26.35 17.46
As on 19-Jul-2024
2023
2022
2021
Gland Pharma
22.07 -59.20 63.08
BSE Mid Cap
45.53 1.38 39.18
BSE Healthcare
36.97 -12.10 20.87

Valuation Score

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Essential Checks

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Gland Pharma Ltd. Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of Gland Pharma Ltd.

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        News & Analysis of Gland Pharma Ltd.

        Other details of Gland Pharma Ltd.

        Incorporated

        1978

        Chairman

        Srinivas Sadu

        Managing Director

        Srinivas Sadu

        Headquarters

        Hyderabad, Telangana

        FAQs for Gland Pharma Ltd.

        The total asset value of Gland Pharma Ltd stood at ₹ 10,661 Cr as on 31-Mar-24

        The share price of Gland Pharma Ltd is ₹1,990.60 (NSE) and ₹1,992.35 (BSE) as of 19-Jul-2024 IST. Gland Pharma Ltd has given a return of -20.47% in the last 3 years.

        Gland Pharma Ltd has a market capitalisation of ₹ 32,824 Cr as on 19-Jul-2024. As per Value Research classification, it is a Mid Cap company.

        The P/B ratio of Gland Pharma Ltd is 3.76 times as on 19-Jul-2024, a 0% premium to its peers’ median range of 3.76 times.

        The P/E ratio of Gland Pharma Ltd is 42.49 times as on 19-Jul-2024, a 51% discount to its peers’ median range of 87.36 times.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Gland Pharma Ltd and enter the required number of quantities and click on buy to purchase the shares of Gland Pharma Ltd.

        Gland Pharma Limited engages in manufacturing and sale of injectable formulation in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. The company engages in research and development of pharmaceutical API products including synthesis of complex drug molecules, such as LMWH, corticosteroids, peptides, and cytotoxic molecules. The company offers its products for various therapeutic categories, such as anti-malarial, anti-infectives, anti-neoplastic, blood related, cardiac, gastro intestinal, gynecological, hormones, neuro/Cns, ophthal/ontological, and other areas, as well as pain and analgesics, respirator, and vitamins, minerals and nutrients; and offers contract development services. The company was incorporated in 1978 and is headquartered in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.

        The promoter of Gland Pharma Ltd is Fosun Pharma Industrial Pte. Ltd. Fosun Pharma Industrial Pte. Ltd owns 51.83 per cent of the total equity. The chairman of the company is Srinivas Sadu , and the managing director is Srinivas Sadu..

        There is no promoter pledging in Gland Pharma Ltd.

        Some of the close peers are:

        Company Market Cap(₹ Cr)
        8,026
        114
        61
        51
        Gland Pharma Ltd. Ratios
        Return on equity(%)
        9.07
        Operating margin(%)
        17.45
        Net Margin(%)
        13.24
        Dividend yield(%)
        --

        Yes, TTM profit after tax of Gland Pharma Ltd was ₹772 Cr.

        Edit peer-selector-edit
        Please wait...
        Please wait...
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information ₹32,824.31 Cr
        • Revenue (TTM)revenue-information ₹5,664.72 Cr
        • Earnings (TTM) earning-information ₹772.46 Cr
        • Cash date-information ₹1,839.43 Cr
        • Total Debt info ₹3.82 Cr
        • Promoters' ownership promoters_ownership 51.83%
        • Liquidity liquidity High
        • 52 Week range week-range ₹1,158.00 - 2,194.00
        • Face value face-value ₹1.00
        • Shares outstanding share-outstanding 16,47,51,723
        • 10 Years Aggregate:

          CFO: ₹3,826.62 Cr

          EBITDA: ₹7,838.05 Cr

          Net Profit: ₹5,696.03 Cr

        About The Company

        • Incorporated 1978
        • Chairman Srinivas Sadu
        • Managing Director Srinivas Sadu
        • Listing key-listing NSE: GLAND, BSE: 543245
        • Country India
        • Headquarters headquarters Hyderabad, Telangana
        • Website website www.glandpharma.com
        • Business

          Gland Pharma Limited engages in manufacturing and sale of injectable formulation in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. The company engages in research and development of pharmaceutical API products...  including synthesis of complex drug molecules, such as LMWH, corticosteroids, peptides, and cytotoxic molecules. The company offers its products for various therapeutic categories, such as anti-malarial, anti-infectives, anti-neoplastic, blood related, cardiac, gastro intestinal, gynecological, hormones, neuro/Cns, ophthal/ontological, and other areas, as well as pain and analgesics, respirator, and vitamins, minerals and nutrients; and offers contract development services. The company was incorporated in 1978 and is headquartered in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.  Read more